Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility.
Ontology highlight
ABSTRACT: The accumulation of advanced glycation end-products (AGEs) in the organic matrix of bone with aging and chronic disease such as diabetes is thought to increase fracture risk independently of bone mass. However, to date, there has not been a clinical trial to determine whether inhibiting the accumulation of AGEs is effective in preventing low-energy, fragility fractures. Moreover, unlike with cardiovascular or kidney disease, there are also no pre-clinical studies demonstrating that AGE inhibitors or breakers can prevent the age- or diabetes-related decrease in the ability of bone to resist fracture. In this review, we critically examine the case for a long-standing hypothesis that AGE accumulation in bone tissue degrades the toughening mechanisms by which bone resists fracture. Prior resea
SUBMITTER: Willett TL
PROVIDER: S-EPMC10062699 | biostudies-literature | 2022 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA